Neuromuscular Diseases in Intensive Care

Author(s)	Yahya Lahrichi, Ali Derkaoui, Ibrahim Bechri, Abdelkrim A Shimi, Mohammed Khatouf
Country	Morocco
Abstract	Guillain-Barre syndrome and myasthenia gravis are common in the intensive care unit (ICU), and are not always easy to diagnose in the emergency department. The short-term risk is the occurrence of respiratory muscle paralysis, which must be monitored by repeated measurement of vital capacity, and the existence of respiratory impairment requires transfer to intensive care. Apart from specific therapeutic options (plasma exchange, intravenous immunoglobulins and anticholinesterase agents), management is mainly symptomatic. Our work is a retrospective study, concerning 23 cases of neuromuscular diseases in the ICU from a period from 2018 to 2022. The various epidemiological, Clinical, paraclinical, Therapeutic and evolutionary data were collected from the files of the intensive Care Department A1 of the Hassan II University Hospital of Fez.
Keywords	respiratory distress- immunoglobulins- nerve stimulation- myasthenia gravis-Guillain-Barré syndrome- nosocomial pneumonia
Field	Medical / Pharmacy
Published In	Volume 5, Issue 5, September-October 2023
Published On	2023-10-02
Cite This	Neuromuscular Diseases in Intensive Care - Yahya Lahrichi, Ali Derkaoui, Ibrahim Bechri, Abdelkrim A Shimi, Mohammed Khatouf - IJFMR Volume 5, Issue 5, September-October 2023. DOI 10.36948/ijfmr.2023.v05i05.7103
DOI	https://doi.org/10.36948/ijfmr.2023.v05i05.7103
Short DOI	https://doi.org/gstc64

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research